Psoriasis News and Research

Latest Psoriasis News and Research

Mother–infant pairs admitted to ICU have poor outcomes

Mother–baby pairs with co-admission to intensive care units after delivery are more likely to experience separation due to interfacility transfer, and have higher mortality rates, than pairs in which either mothers or babies are admitted, show study results.

17 Dec 2012

Cleft palate children need regular hearing check-ups

Children with cleft palate require regular audiologic and otologic follow-up to ensure their management is appropriate and timely, say researchers.

12 Dec 2012

Ultrasonography effective for diagnosing childhood pneumonia

Point-of-care ultrasound scanning can be used to diagnose pneumonia accurately in children and young people, show study findings.

11 Dec 2012

Contrast agent ‘not recommended’ in premature neonates

Premature neonates who are given oral Gastrografin immediately after birth do not pass meconium more quickly than others, study findings suggest.

10 Dec 2012

Mutations signaling poor neuroblastoma prognosis identified

Children with neuroblastoma who have mutations in the ARID1A and ARID1B genes in their tumors have a poor prognosis compared with those without these alterations, show study findings.

4 Dec 2012

Stem cells give insight into path of cytomegalovirus infection

Primitive human stem cells are resistant to human cytomegalovirus, say researchers who believe this finding could provide further insight into disease pathology.

3 Dec 2012

Nontraditional velopharyngoplasty predictor unveiled

The necessity of subsequent velopharyngoplasty does not depend on the time of soft palate closure and type of cleft, say researchers.

28 Nov 2012

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.

28 Nov 2012

Ultrasound puts emergency lines in the right place

Training emergency department staff in use of ultrasound to guide difficult peripheral intravenous catheter placement appears to reduce the unnecessary use of central venous lines, a study suggests.

27 Nov 2012

Child injury fear may take the bounce out of the castle

Injuries sustained while playing on inflatable toys such as bouncy castles have increased at a rapid rate over the last two decades.

26 Nov 2012

$Neonatal history must be taken in ex-preterms with fractures$

Neonatal history must be taken in ex-preterms with fractures

Researchers say that a neonatal history must be taken in all ex-preterm infants with rib fractures.

26 Nov 2012

New therapeutic approach for preventing Alzheimer's disease

Pathological changes typical of Alzheimer's disease were significantly reduced in mice by blockade of an immune system transmitter. A research team from Charité - Universitätsmedizin Berlin and the University of Zurich has just published a new therapeutic approach in fighting Alzheimer's disease in the current issue of Nature Medicine. This approach promises potential in prevention, as well as in cases where the disease has already set in.

26 Nov 2012

Turning off particular cytokines reduces Alzheimer's typical amyloid-- deposits in mice

Alzheimer's disease is one of the most common causes of dementia. In Germany and Switzerland alone, around 1.5 million people are affected, and forecasts predict a doubling of the number of patients worldwide within the next 20 years. The accumulation of particular abnormal proteins, including amyloid-- (Aβ) among others, in patients' brains plays a central role in this disease.

26 Nov 2012

Children with psoriasis at increased risk for obesity

Children with psoriasis have a greater risk for being overweight or obese than those without the disorder, report researchers.

23 Nov 2012

No advantage of continuous over bolus doxorubicin in ALL children

Research suggests that there is no long-term advantage, in terms of cardioprotection or event-free survival, from giving continuous instead of bolus doxorubicin infusion in children with acute lymphoblastic leukemia.

20 Nov 2012

Immunologic diseases linked to poorer survival in PSC

Primary sclerosing cholangitis patients with concomitant immunologic disorders, have reduced transplantation-free survival compared with patients without, say the authors of a German study.

19 Nov 2012

MRI, EEG may predict children’s epilepsy risk after long febrile seizures

Children who have prolonged febrile seizures are at increased risk for magnetic resonance imaging observed hippocampal injury and abnormal hippocampal and temporal development, show results from the Consequences of Prolonged Febrile Seizures in Childhood study.

13 Nov 2012

Hospital quality may affect infant morbidity

Birth in or postnatal transfer to hospitals with a lower level of resources and facilities may negatively impact the health of very preterm infants, show research findings.

6 Nov 2012

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Bristol-Myers Squibb Company is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY (ipilimumab), which is approved in the European Union for the treatment of previously-treated metastatic (advanced) melanoma, within the Final Appraisal Determination (FAD).

3 Nov 2012

Procalcitonin good marker of bacteremia in children with central lines

High procalcitonin levels are a good indicator of bacteremia in children with a central venous catheter who present to the emergency department with fever, suggest study findings.

30 Oct 2012